HF 1877

Introduction - 94th Legislature (2025 - 2026)

Posted on 03/05/2025 11:31 a.m.

A bill for an act
relating to cannabis; modifying medical cannabis and cannabis provisions;
amending Minnesota Statutes 2024, sections 152.22, subdivisions 4, 7, 10, 13;
152.24; 152.25; 152.26; 152.261; 152.27, subdivisions 2, 7; 152.28, subdivisions
1, 3; 152.29, subdivisions 1, 2, 3a, 4; 152.31; 152.32, subdivision 2; 152.33,
subdivisions 1a, 4; 152.35; 152.37; 342.01, subdivisions 9, 47, 54, by adding a
subdivision; 342.02, subdivision 3; 342.12; 342.14, subdivisions 3, 6; 342.151,
subdivisions 2, 3; 342.22, subdivision 3; 342.28, subdivisions 1, 8; 342.29,
subdivisions 1, 7; 342.30, subdivision 1; 342.33, subdivision 1; 342.44, subdivision
1; 342.46, subdivision 6; 342.52, by adding a subdivision; 342.57, subdivision 2;
342.59, subdivision 2; 342.61, subdivision 4; 342.63, subdivisions 2, 3, 6; repealing
Minnesota Statutes 2024, sections 152.22, subdivision 2; 342.01, subdivision 71;
342.151, subdivision 1.

BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF MINNESOTA:

Section 1.

Minnesota Statutes 2024, section 152.22, subdivision 4, is amended to read:

Subd. 4.

Health care practitioner.

"Health care practitioner" means a deleted text begin Minnesota licensed deleted text end new text begin
Minnesota-licensed new text end doctor of medicine, a deleted text begin Minnesota licensed deleted text end new text begin Minnesota-licensed new text end physician
assistant new text begin acting within the scope of authorized practice new text end , or a deleted text begin Minnesota licensed deleted text end new text begin
Minnesota-licensed new text end advanced practice registered nurse who has new text begin an active license in good
standing and new text end the primary responsibility for the care and treatment of the qualifying medical
condition of deleted text begin a person deleted text end new text begin an individual new text end diagnosed with a qualifying medical condition.

Sec. 2.

Minnesota Statutes 2024, section 152.22, subdivision 7, is amended to read:

Subd. 7.

Medical cannabis manufacturer.

"Medical cannabis manufacturer" or
"manufacturer" means an entity registered by the deleted text begin commissioner deleted text end new text begin office new text end to cultivate, acquire,
manufacture, possess, prepare, transfer, transport, supply, or dispense medical cannabis,
delivery devices, or related supplies and educational materials.

Sec. 3.

Minnesota Statutes 2024, section 152.22, subdivision 10, is amended to read:

Subd. 10.

Patient registry number.

"Patient registry number" means a unique
identification number assigned by the deleted text begin commissioner deleted text end new text begin office new text end to a patient enrolled in the registry
program.

Sec. 4.

Minnesota Statutes 2024, section 152.22, subdivision 13, is amended to read:

Subd. 13.

Registry verification.

"Registry verification" means the verification provided
by the deleted text begin commissioner deleted text end new text begin office new text end that a patient is enrolled in the registry program and that includes
the patient's name, registry number, and, if applicable, the name of the patient's registered
designated caregiver or parent, legal guardian, or spouse.

Sec. 5.

Minnesota Statutes 2024, section 152.24, is amended to read:

152.24 FEDERALLY APPROVED CLINICAL TRIALS.

The deleted text begin commissioner deleted text end new text begin office new text end may prohibit enrollment of a patient in the registry program
if the patient is simultaneously enrolled in a federally approved clinical trial for the treatment
of a qualifying medical condition with medical cannabis. The deleted text begin commissioner deleted text end new text begin office new text end shall
provide information to all patients enrolled in the registry program on the existence of
federally approved clinical trials for the treatment of the patient's qualifying medical condition
with medical cannabis as an alternative to enrollment in the patient registry program.

Sec. 6.

Minnesota Statutes 2024, section 152.25, is amended to read:

152.25 deleted text begin COMMISSIONER deleted text end new text begin OFFICE new text end DUTIES.

Subdivision 1.

Medical cannabis manufacturer registration.

(a) The deleted text begin commissioner deleted text end new text begin
office new text end shall register two in-state manufacturers for the production of all medical cannabis
within the state. A registration agreement between the deleted text begin commissioner deleted text end new text begin office new text end and a
manufacturer is nontransferable. The deleted text begin commissioner deleted text end new text begin office new text end shall register new manufacturers
or reregister the existing manufacturers by December 1 every two years, using the factors
described in this subdivision. The deleted text begin commissioner deleted text end new text begin office new text end shall accept applications after
December 1, 2014, if one of the manufacturers registered before December 1, 2014, ceases
to be registered as a manufacturer. The deleted text begin commissioner's deleted text end new text begin office's new text end determination that no
manufacturer exists to fulfill the duties under sections 152.22 to 152.37 is subject to judicial
review in Ramsey County District Court. Data submitted during the application process are
private data on individuals or nonpublic data as defined in section 13.02 until the
manufacturer is registered under this section. Data on a manufacturer that is registered are
public data, unless the data are trade secret or security information under section 13.37.

(b) As a condition for registration, a manufacturer must agree to:

(1) begin supplying medical cannabis to patients by July 1, 2015; and

(2) comply with all requirements under sections 152.22 to 152.37.

(c) The deleted text begin commissioner deleted text end new text begin office new text end shall consider the following factors when determining
which manufacturer to register:

(1) the technical expertise of the manufacturer in cultivating medical cannabis and
converting the medical cannabis into an acceptable delivery method under section 152.22,
subdivision 6;

(2) the qualifications of the manufacturer's employees;

(3) the long-term financial stability of the manufacturer;

(4) the ability to provide appropriate security measures on the premises of the
manufacturer;

(5) whether the manufacturer has demonstrated an ability to meet the medical cannabis
production needs required by sections 152.22 to 152.37; and

(6) the manufacturer's projection and ongoing assessment of fees on patients with a
qualifying medical condition.

(d) If an officer, director, or controlling person of the manufacturer pleads or is found
guilty of intentionally diverting medical cannabis to a person other than allowed by law
under section 152.33, subdivision 1, the deleted text begin commissioner deleted text end new text begin office new text end may decide not to renew the
registration of the manufacturer, provided the violation occurred while the person was an
officer, director, or controlling person of the manufacturer.

(e) The deleted text begin commissioner deleted text end new text begin office new text end shall require each medical cannabis manufacturer to contract
with an independent laboratory to test medical cannabis produced by the manufacturer. The
deleted text begin commissioner deleted text end new text begin office new text end shall approve the laboratory chosen by each manufacturer and require
that the laboratory report testing results to the manufacturer in a manner determined by the
deleted text begin commissioner deleted text end new text begin office new text end .

Subd. 1a.

Revocation or nonrenewal of a medical cannabis manufacturer
registration.

If the deleted text begin commissioner deleted text end new text begin office new text end intends to revoke or not renew a registration issued
under this section, the deleted text begin commissioner deleted text end new text begin office new text end must first notify in writing the manufacturer
against whom the action is to be taken and provide the manufacturer with an opportunity
to request a hearing under the contested case provisions of chapter 14. If the manufacturer
does not request a hearing by notifying the deleted text begin commissioner deleted text end new text begin office new text end in writing within 20 days
after receipt of the notice of proposed action, the deleted text begin commissioner deleted text end new text begin office new text end may proceed with
the action without a hearing. For revocations, the registration of a manufacturer is considered
revoked on the date specified in the deleted text begin commissioner's deleted text end new text begin office's new text end written notice of revocation.

Subd. 1b.

Temporary suspension proceedings.

The deleted text begin commissioner deleted text end new text begin office new text end may institute
proceedings to temporarily suspend the registration of a medical cannabis manufacturer for
a period of up to 90 days by notifying the manufacturer in writing if any action by an
employee, agent, officer, director, or controlling person of the manufacturer:

(1) violates any of the requirements of sections 152.22 to 152.37 or the rules adopted
thereunder;

(2) permits, aids, or abets the commission of any violation of state law at the
manufacturer's location for cultivation, harvesting, manufacturing, packaging, and processing
or at any site for distribution of medical cannabis;

(3) performs any act contrary to the welfare of a registered patient or registered designated
caregiver; or

(4) obtains, or attempts to obtain, a registration by fraudulent means or misrepresentation.

Subd. 1c.

Notice to patients.

Upon the revocation or nonrenewal of a manufacturer's
registration under subdivision 1a or implementation of an enforcement action under
subdivision 1b that may affect the ability of a registered patient, registered designated
caregiver, or a registered patient's parent, legal guardian, or spouse to obtain medical cannabis
from the manufacturer subject to the enforcement action, the deleted text begin commissioner deleted text end new text begin office new text end shall
notify in writing each registered patient and the patient's registered designated caregiver or
registered patient's parent, legal guardian, or spouse about the outcome of the proceeding
and information regarding alternative registered manufacturers. This notice must be provided
two or more business days prior to the effective date of the revocation, nonrenewal, or other
enforcement action.

Subd. 2.

Range of compounds and dosages; report.

The office shall review and publicly
report the existing medical and scientific literature regarding the range of recommended
dosages for each qualifying condition and the range of chemical compositions of any plant
of the genus cannabis that will likely be medically beneficial for each of the qualifying
medical conditions. The office shall make this information available to patients with
qualifying medical conditions beginning December 1, 2014, and update the information
every three years. The office may consult with the independent laboratory under contract
with the manufacturer or other experts in reporting the range of recommended dosages for
each qualifying medical condition, the range of chemical compositions that will likely be
medically beneficial, and any risks of noncannabis drug interactions. The office shall consult
with each manufacturer on an annual basis on medical cannabis offered by the manufacturer.
The list of medical cannabis offered by a manufacturer shall be published on the Office of
Cannabis Management website.

Subd. 3.

Deadlines.

The deleted text begin commissioner deleted text end new text begin office new text end shall adopt rules necessary for the
manufacturer to begin distribution of medical cannabis to patients under the registry program
by July 1, 2015, and have notice of proposed rules published in the State Register prior to
January 1, 2015.

Subd. 4.

Reports.

(a) The deleted text begin commissioner deleted text end new text begin office new text end shall provide regular updates to the deleted text begin task
force on medical cannabis therapeutic research and to the chairs and ranking minority
members of the legislative committees with jurisdiction over health and human services,
public safety, judiciary, and civil law deleted text end new text begin Cannabis Advisory Council under section 342.03 new text end
regarding: (1) any changes in federal law or regulatory restrictions regarding the use of
medical cannabis or hemp; and (2) the market demand and supply in this state for products
made from hemp that can be used for medicinal purposes.

(b) The deleted text begin commissioner deleted text end new text begin office new text end may submit medical research based on the data collected
under sections 152.22 to 152.37 to any federal agency with regulatory or enforcement
authority over medical cannabis to demonstrate the effectiveness of medical cannabis for
treating a qualifying medical condition.

Sec. 7.

Minnesota Statutes 2024, section 152.26, is amended to read:

152.26 RULEMAKING.

(a) The deleted text begin commissioner deleted text end new text begin office new text end may adopt rules to implement sections 152.22 to 152.37.
Rules for which notice is published in the State Register before January 1, 2015, may be
adopted using the process in section 14.389.

(b) The deleted text begin commissioner deleted text end new text begin office new text end may adopt or amend rules, using the procedure in section
14.386, paragraph (a), to implement the addition of dried raw cannabis as an allowable form
of medical cannabis under section 152.22, subdivision 6, paragraph (a), clause (4). Section
14.386, paragraph (b), does not apply to these rules.

Sec. 8.

Minnesota Statutes 2024, section 152.261, is amended to read:

152.261 RULES; ADVERSE INCIDENTS.

(a) The deleted text begin commissioner of health deleted text end new text begin office new text end shall adopt rules to establish requirements for
reporting incidents when individuals who are not authorized to possess medical cannabis
under sections 152.22 to 152.37 are found in possession of medical cannabis. The rules
must identify professionals required to report, the information they are required to report,
and actions the reporter must take to secure the medical cannabis.

(b) The deleted text begin commissioner of health deleted text end new text begin office new text end shall adopt rules to establish requirements for law
enforcement officials and health care professionals to report incidents involving an overdose
of medical cannabis to the deleted text begin commissioner of health deleted text end new text begin office new text end .

(c) Rules must include the method by which the deleted text begin commissioner deleted text end new text begin office new text end will collect and
tabulate reports of unauthorized possession and overdose.

Sec. 9.

Minnesota Statutes 2024, section 152.27, subdivision 2, is amended to read:

Subd. 2.

Office duties.

(a) The office shall:

(1) give notice of the program to health care practitioners in the state deleted text begin who are eligible
to serve as health care practitioners and explain the purposes and requirements of the
program deleted text end ;

(2) allow each health care practitioner who meets or agrees to meet the program's
requirements and who requests to participate, to be included in the registry program deleted text begin to
collect data for the patient registry deleted text end ;

(3) provide explanatory information and assistance to each health care practitioner in
understanding the nature of therapeutic use of medical cannabis within program requirements;

(4) create and provide a certification to be used by a health care practitioner for the
practitioner to certify whether a patient has been diagnosed with a qualifying medical
condition;

(5) supervise the participation of the health care practitioner in conducting patient
treatment and health records reporting in a manner that ensures stringent security and
record-keeping requirements and that prevents the unauthorized release of private data on
individuals as defined by section 13.02;

(6) develop safety criteria for patients with a qualifying medical condition as a
requirement of the patient's participation in the program, to prevent the patient from
undertaking any task under the influence of medical cannabis that would constitute negligence
or professional malpractice on the part of the patient; and

(7) conduct research and studies based on data from health records submitted to the
registry program and submit reports on intermediate or final research results to the legislature
and major scientific journals. The office may contract with a third party to complete the
requirements of this clause. Any reports submitted must comply with section 152.28,
subdivision 2.

(b) The office may add a delivery method under section 152.22, subdivision 6, upon a
petition from a member of the public or the Cannabis Advisory Council under section 342.03
or as directed by law. If the office wishes to add a delivery method under section 152.22,
subdivision 6, the office must notify the chairs and ranking minority members of the
legislative policy committees having jurisdiction over health and public safety of the addition
and the reasons for its addition, including any written comments received by the office from
the public and any guidance received from the Cannabis Advisory Council under section
342.03, by January 15 of the year in which the office wishes to make the change. The change
shall be effective on August 1 of that year, unless the legislature by law provides otherwise.

Sec. 10.

Minnesota Statutes 2024, section 152.27, subdivision 7, is amended to read:

Subd. 7.

Notice requirements.

Patients and registered designated caregivers shall notify
the deleted text begin commissioner deleted text end new text begin office new text end of any address or name change within 30 days of the change having
occurred. A patient or registered designated caregiver is subject to a $100 fine for failure
to notify the deleted text begin commissioner deleted text end new text begin office new text end of the change.

Sec. 11.

Minnesota Statutes 2024, section 152.28, subdivision 1, is amended to read:

Subdivision 1.

Health care practitioner duties.

(a) Prior to a patient's enrollment in
the registry program, a health care practitioner shall:

(1) determine, in the health care practitioner's medical judgment, whether a patient suffers
from a qualifying medical condition, and, if so determined, provide the patient with a
certification of that diagnosis;

(2) advise patients, registered designated caregivers, and parents, legal guardians, or
spouses who are acting as caregivers of the existence of any nonprofit patient support groups
or organizations;

(3) provide explanatory information from the office to patients with qualifying medical
conditions, including disclosure to all patients about the experimental nature of therapeutic
use of medical cannabis; the possible risks, benefits, and side effects of the proposed
treatment; the application and other materials from the office; and provide patients with the
Tennessen warning as required by section 13.04, subdivision 2; and

(4) agree to continue treatment of the patient's qualifying medical condition and report
medical findings to the office.

(b) Upon notification from the office of the patient's enrollment in the registry program,
the health care practitioner shall:

(1) participate in the patient registry reporting system under the guidance and supervision
of the office;

(2) report health records of the patient throughout the ongoing treatment of the patient
to the office in a manner determined by the deleted text begin commissioner deleted text end new text begin office new text end and in accordance with
subdivision 2;

(3) determine, every three years, if the patient continues to suffer from a qualifying
medical condition and, if so, issue the patient a new certification of that diagnosis; and

(4) otherwise comply with all requirements developed by the office.

(c) A health care practitioner may utilize telehealth, as defined in section 62A.673,
subdivision 2, for certifications and recertifications.

(d) Nothing in this section requires a health care practitioner to participate in the registry
program.

Sec. 12.

Minnesota Statutes 2024, section 152.28, subdivision 3, is amended to read:

Subd. 3.

Advertising restrictions.

(a) A health care practitioner shall not publish or
cause to be published any advertisement that:

(1) contains false or misleading statements about medical cannabis or about the medical
cannabis registry program;

(2) uses colloquial terms to refer to medical cannabis, such as pot, weed, or grass;

(3) states or implies the health care practitioner is endorsed by the deleted text begin Department of Health deleted text end new text begin
office new text end or by the medical cannabis registry program;

(4) includes images of cannabis in its plant or leaf form or of cannabis-smoking
paraphernalia; or

(5) contains medical symbols that could reasonably be confused with symbols of
established medical associations or groups.

(b) A health care practitioner found by the deleted text begin commissioner deleted text end new text begin office new text end to have violated this
subdivision is prohibited from certifying that patients have a qualifying medical condition
for purposes of patient participation in the registry program. The deleted text begin commissioner's deleted text end new text begin office's new text end
decision that a health care practitioner has violated this subdivision is a final decision of
the deleted text begin commissioner deleted text end new text begin office new text end and is not subject to the contested case procedures in chapter 14.

Sec. 13.

Minnesota Statutes 2024, section 152.29, subdivision 1, is amended to read:

Subdivision 1.

Manufacturer; requirements.

(a) A manufacturer may operate eight
distribution facilities, which may include the manufacturer's single location for cultivation,
harvesting, manufacturing, packaging, and processing but is not required to include that
location. The deleted text begin commissioner deleted text end new text begin office new text end shall designate the geographical service areas to be served
by each manufacturer based on geographical need throughout the state to improve patient
access. A manufacturer shall not have more than two distribution facilities in each
geographical service area assigned to the manufacturer by the deleted text begin commissioner deleted text end new text begin office new text end . A
manufacturer shall operate only one location where all cultivation, harvesting, manufacturing,
packaging, and processing of medical cannabis shall be conducted. This location may be
one of the manufacturer's distribution facility sites. The additional distribution facilities
may dispense medical cannabis and medical cannabis products but may not contain any
medical cannabis in a form other than those forms allowed under section 152.22, subdivision
6, and the manufacturer shall not conduct any cultivation, harvesting, manufacturing,
packaging, or processing at the other distribution facility sites. Any distribution facility
operated by the manufacturer is subject to all of the requirements applying to the
manufacturer under sections 152.22 to 152.37, including, but not limited to, security and
distribution requirements.

(b) A manufacturer may acquire hemp grown in this state from a hemp grower, and may
acquire hemp products produced by a hemp processor. A manufacturer may manufacture
or process hemp and hemp products into an allowable form of medical cannabis under
section 152.22, subdivision 6. Hemp and hemp products acquired by a manufacturer under
this paragraph are subject to the same quality control program, security and testing
requirements, and other requirements that apply to medical cannabis under sections 152.22
to 152.37 and Minnesota Rules, chapter 4770.

(c) A medical cannabis manufacturer shall contract with a laboratory approved by the
deleted text begin commissioner deleted text end new text begin office new text end , subject to any additional requirements set by the deleted text begin commissioner deleted text end new text begin office new text end ,
for purposes of testing medical cannabis manufactured or hemp or hemp products acquired
by the medical cannabis manufacturer as to content, contamination, and consistency to
verify the medical cannabis meets the requirements of section 152.22, subdivision 6. The
cost of laboratory testing shall be paid by the manufacturer.

(d) The operating documents of a manufacturer must include:

(1) procedures for the oversight of the manufacturer and procedures to ensure accurate
record keeping;

(2) procedures for the implementation of appropriate security measures to deter and
prevent the theft of medical cannabis and unauthorized entrance into areas containing medical
cannabis; and

(3) procedures for the delivery and transportation of hemp between hemp growers and
manufacturers and for the delivery and transportation of hemp products between hemp
processors and manufacturers.

(e) A manufacturer shall implement security requirements, including requirements for
the delivery and transportation of hemp and hemp products, protection of each location by
a fully operational security alarm system, facility access controls, perimeter intrusion
detection systems, and a personnel identification system.

(f) A manufacturer shall not share office space with, refer patients to a health care
practitioner, or have any financial relationship with a health care practitioner.

(g) A manufacturer shall not permit any person to consume medical cannabis on the
property of the manufacturer.

(h) A manufacturer is subject to reasonable inspection by the deleted text begin commissioner deleted text end new text begin office new text end .

(i) For purposes of sections 152.22 to 152.37, a medical cannabis manufacturer is not
subject to the Board of Pharmacy licensure or regulatory requirements under chapter 151.

(j) A medical cannabis manufacturer may not employ any person who is under 21 years
of age or who has been convicted of a disqualifying felony offense. An employee of a
medical cannabis manufacturer must submit a completed criminal history records check
consent form, a full set of classifiable fingerprints, and the required fees for submission to
the Bureau of Criminal Apprehension before an employee may begin working with the
manufacturer. The bureau must conduct a Minnesota criminal history records check and
the superintendent is authorized to exchange the fingerprints with the Federal Bureau of
Investigation to obtain the applicant's national criminal history record information. The
bureau shall return the results of the Minnesota and federal criminal history records checks
to the deleted text begin commissioner deleted text end new text begin office new text end .

(k) A manufacturer may not operate in any location, whether for distribution or
cultivation, harvesting, manufacturing, packaging, or processing, within 1,000 feet of a
public or private school existing before the date of the manufacturer's registration with the
deleted text begin commissioner deleted text end new text begin office new text end .

(l) A manufacturer shall comply with reasonable restrictions set by the deleted text begin commissioner deleted text end new text begin
office new text end relating to signage, marketing, display, and advertising of medical cannabis.

(m) Before a manufacturer acquires hemp from a hemp grower or hemp products from
a hemp processor, the manufacturer must verify that the hemp grower or hemp processor
has a valid license issued by the commissioner of agriculture under chapter 18K.

(n) Until a state-centralized, seed-to-sale system is implemented that can track a specific
medical cannabis plant from cultivation through testing and point of sale, the deleted text begin commissioner deleted text end new text begin
office new text end shall conduct at least one unannounced inspection per year of each manufacturer that
includes inspection of:

(1) business operations;

(2) physical locations of the manufacturer's manufacturing facility and distribution
facilities;

(3) financial information and inventory documentation, including laboratory testing
results; and

(4) physical and electronic security alarm systems.

Sec. 14.

Minnesota Statutes 2024, section 152.29, subdivision 2, is amended to read:

Subd. 2.

Manufacturer; production.

(a) A manufacturer of medical cannabis shall
provide a reliable and ongoing supply of all medical cannabis needed for the registry program
through cultivation by the manufacturer and through the purchase of hemp from hemp
growers.

(b) All cultivation, harvesting, manufacturing, packaging, and processing of medical
cannabis must take place in an enclosed, locked facility at a physical address provided to
the deleted text begin commissioner deleted text end new text begin office new text end during the registration process.

(c) A manufacturer must process and prepare any medical cannabis plant material or
hemp plant material into a form allowable under section 152.22, subdivision 6, prior to
distribution of any medical cannabis.

Sec. 15.

Minnesota Statutes 2024, section 152.29, subdivision 3a, is amended to read:

Subd. 3a.

Transportation of medical cannabis; transport staffing.

(a) A medical
cannabis manufacturer may staff a transport motor vehicle with only one employee if the
medical cannabis manufacturer is transporting medical cannabis to either a certified
laboratory for the purpose of testing or a facility for the purpose of disposal. If the medical
cannabis manufacturer is transporting medical cannabis for any other purpose or destination,
the transport motor vehicle must be staffed with a minimum of two employees as required
by rules adopted by the deleted text begin commissioner deleted text end new text begin office new text end .

(b) Notwithstanding paragraph (a), a medical cannabis manufacturer that is only
transporting hemp for any purpose may staff the transport motor vehicle with only one
employee.

(c) A medical cannabis manufacturer may contract with a third party for armored car
services for deliveries of medical cannabis from its production facility to distribution
facilities. A medical cannabis manufacturer that contracts for armored car services remains
responsible for the transportation manifest and inventory tracking requirements in rules
adopted by the deleted text begin commissioner deleted text end new text begin office new text end .

(d) deleted text begin Department of Health deleted text end new text begin Office new text end staff may transport medical cannabis for the purposes
of delivering medical cannabis and other samples to a laboratory for testing under rules
adopted by the deleted text begin commissioner deleted text end new text begin office new text end and in cases of special investigations when the
deleted text begin commissioner deleted text end new text begin office new text end has determined there is a potential threat to public health. The transport
motor vehicle must be staffed with a minimum of two deleted text begin Department of Health deleted text end new text begin office new text end
employees. The employees must carry with them their deleted text begin Department of Health deleted text end new text begin office new text end
identification card and a transport manifest.

Sec. 16.

Minnesota Statutes 2024, section 152.29, subdivision 4, is amended to read:

Subd. 4.

Report.

(a) Each manufacturer shall report to the deleted text begin commissioner deleted text end new text begin office new text end on a
monthly basis the following information on each individual patient for the month prior to
the report:

(1) the amount and dosages of medical cannabis distributed;

(2) the chemical composition of the medical cannabis; and

(3) the tracking number assigned to any medical cannabis distributed.

(b) For transactions involving Tribal medical cannabis program patients, each
manufacturer shall report to the deleted text begin commissioner deleted text end new text begin office new text end on a weekly basis the following
information on each individual Tribal medical cannabis program patient for the week prior
to the report:

(1) the name of the Tribal medical cannabis program in which the Tribal medical cannabis
program patient is enrolled;

(2) the amount and dosages of medical cannabis distributed;

(3) the chemical composition of the medical cannabis distributed; and

(4) the tracking number assigned to the medical cannabis distributed.

Sec. 17.

Minnesota Statutes 2024, section 152.31, is amended to read:

152.31 DATA PRACTICES.

(a) Government data in patient files maintained by the deleted text begin commissioner deleted text end new text begin office new text end and the
health care practitioner, and data submitted to or by a medical cannabis manufacturer, are
private data on individuals, as defined in section 13.02, subdivision 12, or nonpublic data,
as defined in section 13.02, subdivision 9, but may be used for purposes of complying with
chapter 13 and complying with a request from the legislative auditor or the state auditor in
the performance of official duties. The provisions of section 13.05, subdivision 11, apply
to a registration agreement entered between the deleted text begin commissioner deleted text end new text begin office new text end and a medical cannabis
manufacturer under section 152.25.

(b) Not public data maintained by the deleted text begin commissioner deleted text end new text begin office new text end may not be used for any
purpose not provided for in sections 152.22 to 152.37, and may not be combined or linked
in any manner with any other list, dataset, or database.

(c) The deleted text begin commissioner deleted text end new text begin office new text end may execute data sharing arrangements with the
commissioner of agriculture to verify licensing, inspection, and compliance information
related to hemp growers and hemp processors under chapter 18K.

Sec. 18.

Minnesota Statutes 2024, section 152.32, subdivision 2, is amended to read:

Subd. 2.

Criminal and civil protections.

(a) Subject to section 152.23, the following
are not violations under this chapter:

(1) use or possession of medical cannabis or medical cannabis products by a patient
enrolled in the registry program; possession by a registered designated caregiver or the
parent, legal guardian, or spouse of a patient if the parent, legal guardian, or spouse is listed
on the registry verification; or use or possession of medical cannabis or medical cannabis
products by a Tribal medical cannabis program patient;

(2) possession, dosage determination, or sale of medical cannabis or medical cannabis
products by a medical cannabis manufacturer, employees of a manufacturer, a Tribal medical
cannabis program manufacturer, employees of a Tribal medical cannabis program
manufacturer, a laboratory conducting testing on medical cannabis, or employees of the
laboratory; and

(3) possession of medical cannabis or medical cannabis products by any person while
carrying out the duties required under sections 152.22 to 152.37.

(b) Medical cannabis obtained and distributed pursuant to sections 152.22 to 152.37 and
associated property is not subject to forfeiture under sections 609.531 to 609.5316.

(c) The deleted text begin commissioner deleted text end new text begin office new text end , members of a Tribal medical cannabis board, the
deleted text begin commissioner's deleted text end new text begin office's new text end or Tribal medical cannabis board's staff, the deleted text begin commissioner's deleted text end new text begin office's new text end
or Tribal medical cannabis board's agents or contractors, and any health care practitioner
are not subject to any civil or disciplinary penalties by the Board of Medical Practice, the
Board of Nursing, or by any business, occupational, or professional licensing board or entity,
solely for participation in the registry program under sections 152.22 to 152.37 or in a Tribal
medical cannabis program. A pharmacist licensed under chapter 151 is not subject to any
civil or disciplinary penalties by the Board of Pharmacy when acting in accordance with
the provisions of sections 152.22 to 152.37. Nothing in this section affects a professional
licensing board from taking action in response to violations of any other section of law.

(d) Notwithstanding any law to the contrary, the deleted text begin commissioner deleted text end new text begin office new text end , the governor of
Minnesota, or an employee of any state agency may not be held civilly or criminally liable
for any injury, loss of property, personal injury, or death caused by any act or omission
while acting within the scope of office or employment under sections 152.22 to 152.37.

(e) Federal, state, and local law enforcement authorities are prohibited from accessing
the patient registry under sections 152.22 to 152.37 except when acting pursuant to a valid
search warrant.

(f) Notwithstanding any law to the contrary, neither the deleted text begin commissioner deleted text end new text begin office new text end nor a public
employee may release data or information about an individual contained in any report,
document, or registry created under sections 152.22 to 152.37 or any information obtained
about a patient participating in the program, except as provided in sections 152.22 to 152.37.

(g) No information contained in a report, document, or registry or obtained from a patient
under sections 152.22 to 152.37 or from a Tribal medical cannabis program patient may be
admitted as evidence in a criminal proceeding unless independently obtained or in connection
with a proceeding involving a violation of sections 152.22 to 152.37.

(h) Notwithstanding section 13.09, any person who violates paragraph (e) or (f) is guilty
of a gross misdemeanor.

(i) An attorney may not be subject to disciplinary action by the Minnesota Supreme
Court, a Tribal court, or the professional responsibility board for providing legal assistance
to prospective or registered manufacturers or others related to activity that is no longer
subject to criminal penalties under state law pursuant to sections 152.22 to 152.37, or for
providing legal assistance to a Tribal medical cannabis program or a Tribal medical cannabis
program manufacturer.

(j) The following do not constitute probable cause or reasonable suspicion, and shall not
be used to support a search of the person or property of the person possessing or applying
for the registry verification or equivalent, or otherwise subject the person or property of the
person to inspection by any governmental agency:

(1) possession of a registry verification or application for enrollment in the registry
program by a person entitled to possess a registry verification or apply for enrollment in
the registry program; or

(2) possession of a verification or equivalent issued by a Tribal medical cannabis program
or application for enrollment in a Tribal medical cannabis program by a person entitled to
possess such a verification or application.

Sec. 19.

Minnesota Statutes 2024, section 152.33, subdivision 1a, is amended to read:

Subd. 1a.

Intentional diversion outside the state; penalties.

(a) In addition to any other
applicable penalty in law, the deleted text begin commissioner deleted text end new text begin office new text end may levy a fine of $250,000 against a
manufacturer and may immediately initiate proceedings to revoke the manufacturer's
registration, using the procedure in section 152.25, if:

(1) an officer, director, or controlling person of the manufacturer pleads or is found
guilty under subdivision 1 of intentionally transferring medical cannabis, while the person
was an officer, director, or controlling person of the manufacturer, to a person other than
allowed by law; and

(2) in intentionally transferring medical cannabis to a person other than allowed by law,
the officer, director, or controlling person transported or directed the transport of medical
cannabis outside of Minnesota.

(b) All fines collected under this subdivision shall be deposited in the state government
special revenue fund.

Sec. 20.

Minnesota Statutes 2024, section 152.33, subdivision 4, is amended to read:

Subd. 4.

Submission of false records; criminal penalty.

A person who knowingly
submits false records or documentation required by the deleted text begin commissioner deleted text end new text begin office new text end to register as
a manufacturer of medical cannabis under sections 152.22 to 152.37 is guilty of a felony
and may be sentenced to imprisonment for not more than two years or by payment of a fine
of not more than $3,000, or both.

Sec. 21.

Minnesota Statutes 2024, section 152.35, is amended to read:

152.35 FEES; DEPOSIT OF REVENUE.

(a) The deleted text begin commissioner deleted text end new text begin office new text end shall collect an application fee of $20,000 from each entity
submitting an application for registration as a medical cannabis manufacturer. Revenue
from the fee shall be deposited in the state treasury and credited to the state government
special revenue fund.

(b) The deleted text begin commissioner deleted text end new text begin office new text end shall establish and collect an annual fee from a medical
cannabis manufacturer equal to the cost of regulating and inspecting the manufacturer in
that year. Revenue from the fee amount shall be deposited in the state treasury and credited
to the state government special revenue fund.

(c) A medical cannabis manufacturer may charge patients enrolled in the registry program
a reasonable fee for costs associated with the operations of the manufacturer. The
manufacturer may establish a sliding scale of patient fees based upon a patient's household
income and may accept private donations to reduce patient fees.

Sec. 22.

Minnesota Statutes 2024, section 152.37, is amended to read:

152.37 FINANCIAL EXAMINATIONS; PRICING REVIEWS.

Subdivision 1.

Financial records.

A medical cannabis manufacturer shall maintain
detailed financial records in a manner and format approved by the deleted text begin commissioner deleted text end new text begin office new text end ,
and shall keep all records updated and accessible to the deleted text begin commissioner deleted text end new text begin office new text end when requested.

Subd. 2.

Certified annual audit.

A medical cannabis manufacturer shall submit the
results of an annual certified financial audit to the deleted text begin commissioner deleted text end new text begin office new text end no later than May
1 of each year for the calendar year beginning January 2015. The annual audit shall be
conducted by an independent certified public accountant and the costs of the audit are the
responsibility of the medical cannabis manufacturer. Results of the audit shall be provided
to the medical cannabis manufacturer and the deleted text begin commissioner deleted text end new text begin office new text end . The deleted text begin commissioner deleted text end new text begin office new text end
may also require another audit of the medical cannabis manufacturer by a certified public
accountant chosen by the deleted text begin commissioner deleted text end new text begin office new text end with the costs of the audit paid by the medical
cannabis manufacturer.

Subd. 3.

Power to examine.

(a) The deleted text begin commissioner deleted text end new text begin office new text end or designee may examine the
business affairs and conditions of any medical cannabis manufacturer, including but not
limited to a review of the financing, budgets, revenues, sales, and pricing.

(b) An examination may cover the medical cannabis manufacturer's business affairs,
practices, and conditions including but not limited to a review of the financing, budgets,
revenues, sales, and pricing. The deleted text begin commissioner deleted text end new text begin office new text end shall determine the nature and scope
of each examination and in doing so shall take into account all available relevant factors
concerning the financial and business affairs, practices, and conditions of the examinee.
The costs incurred by the department in conducting an examination shall be paid for by the
medical cannabis manufacturer.

(c) When making an examination under this section, the deleted text begin commissioner deleted text end new text begin office new text end may retain
attorneys, appraisers, independent economists, independent certified public accountants, or
other professionals and specialists as designees. A certified public accountant retained by
the deleted text begin commissioner deleted text end new text begin office new text end may not be the same certified public accountant providing the
certified annual audit in subdivision 2.

(d) The deleted text begin commissioner deleted text end new text begin office new text end shall make a report of an examination conducted under this
section and provide a copy to the medical cannabis manufacturer. The deleted text begin commissioner deleted text end new text begin office new text end
shall then post a copy of the report on the department's website. All working papers, recorded
information, documents, and copies produced by, obtained by, or disclosed to the
deleted text begin commissioner deleted text end new text begin office new text end or any other person in the course of an examination, other than the
information contained in any deleted text begin commissioner deleted text end new text begin office new text end official report, made under this section
are private data on individuals or nonpublic data, as defined in section 13.02.

Sec. 23.

Minnesota Statutes 2024, section 342.01, subdivision 9, is amended to read:

Subd. 9.

Bona fide labor organization.

"Bona fide labor organization" means a labor
union that represents or is actively seeking to represent deleted text begin cannabis deleted text end workers deleted text begin . deleted text end new text begin of:
new text end

new text begin (1) a cannabis business; or
new text end

new text begin (2) a lower-potency hemp edible manufacturer.
new text end

Sec. 24.

Minnesota Statutes 2024, section 342.01, subdivision 47, is amended to read:

Subd. 47.

Labor peace agreement.

"Labor peace agreement" means an agreement
between a cannabis business and a bona fide labor organization new text begin or an agreement between
a lower-potency hemp edible manufacturer and a bona fide labor organization new text end that protects
the state's interests by, at minimum, prohibiting the labor organization from engaging in
picketing, work stoppages, or boycotts against the cannabis business new text begin or lower-potency hemp
edible manufacturer new text end .

Sec. 25.

Minnesota Statutes 2024, section 342.01, subdivision 54, is amended to read:

Subd. 54.

Medical cannabis flower.

"Medical cannabis flower" means cannabis flower
provided to a patient enrolled in the registry program deleted text begin or a visiting patient deleted text end ; a registered
designated caregiver; or a parent, legal guardian, or spouse of an enrolled patient by a
registered designated caregiver, cannabis retailer, or cannabis business with a medical
cannabis retail endorsement to treat or alleviate the symptoms of a qualifying medical
condition. Medical cannabis flower does not include adult-use cannabis flower.

Sec. 26.

Minnesota Statutes 2024, section 342.01, is amended by adding a subdivision to
read:

new text begin Subd. 54a. new text end

new text begin Medical cannabis paraphernalia. new text end

new text begin "Medical cannabis paraphernalia" means
a delivery device, related supply, or educational material used by a patient enrolled in the
registry program to administer medical cannabis and medical cannabinoid products.
new text end

Sec. 27.

Minnesota Statutes 2024, section 342.02, subdivision 3, is amended to read:

Subd. 3.

Medical cannabis program.

(a) The powers and duties of the Department of
Health with respect to the medical cannabis program under Minnesota Statutes 2022, sections
152.22 to 152.37, are transferred to the Office of Cannabis Management under section
15.039.

(b) The following protections shall apply to employees who are transferred from the
Department of Health to the Office of Cannabis Management:

(1) the employment status and job classification of a transferred employee shall not be
altered as a result of the transfer;

(2) transferred employees who were represented by an exclusive representative prior to
the transfer shall continue to be represented by the same exclusive representative after the
transfer;

(3) the applicable collective bargaining agreements with exclusive representatives shall
continue in full force and effect for such transferred employees after the transfer;

(4) the state must meet and negotiate with the exclusive representatives of the transferred
employees about any proposed changes affecting or relating to the transferred employees'
terms and conditions of employment to the extent such changes are not addressed in the
applicable collective bargaining agreement; and

(5) for an employee in a temporary unclassified position transferred to the Office of
Cannabis Management, the total length of time that the employee has served in the
appointment shall include all time served in the appointment and the transferring agency
and the time served in the appointment at the Office of Cannabis Management. An employee
in a temporary unclassified position who was hired by a transferring agency through an
open competitive selection process in accordance with a policy enacted by Minnesota
Management and Budget shall be considered to have been hired through such process after
the transfer.

deleted text begin (c) This subdivision is effective July 1, 2024.
deleted text end

Sec. 28.

Minnesota Statutes 2024, section 342.12, is amended to read:

342.12 LICENSES; TRANSFERS; ADJUSTMENTS.

(a) Licenses issued under this chapter that are available to all applicants pursuant to
section 342.14, subdivision 1b, paragraph (c), may be freely transferred subject to the prior
written approval of the office unless the license holder has not received a final site inspection
or the license holder is a social equity applicant.

(b) Licenses issued as social equity licenses pursuant to either section 342.14, subdivision
1b, paragraph (b), or section 342.175, paragraph (b), may only be transferred to another
social equity applicant for three years after the date on which the office issues the license.
Three years after the date of issuance, a license holder may transfer a license to any entity.
Transfer of a license that was issued as a social equity license must be reviewed by the
Division of Social Equity and is subject to the prior written approval of the office.

(c) new text begin Preliminary new text end license deleted text begin preapproval deleted text end new text begin approval new text end issued pursuant to section deleted text begin 342.125 deleted text end new text begin 342.14,
subdivision 5, new text end may not be transferred.

(d) A new license must be obtained when:

(1) the form of the licensee's legal business structure converts or changes to a different
type of legal business structure; or

(2) the licensee dissolves; consolidates; reorganizes; undergoes bankruptcy, insolvency,
or receivership proceedings; merges with another legal organization; or assigns all or
substantially all of its assets for the benefit of creditors.

(e) Licenses must be renewed annually.

(f) License holders may petition the office to adjust the tier of a license issued within a
license category if the license holder meets all applicable requirements.

(g) The office by rule may permit the relocation of a licensed cannabis business; permit
the relocation of an approved operational location, including a cultivation, manufacturing,
processing, or retail location; adopt requirements for the submission of a license relocation
application; establish standards for the approval of a relocation application; and charge a
fee not to exceed $250 for reviewing and processing applications. Relocation of a licensed
premises pursuant to this paragraph does not extend or otherwise modify the license term
of the license subject to relocation.

Sec. 29.

Minnesota Statutes 2024, section 342.14, subdivision 3, is amended to read:

Subd. 3.

Review.

(a) After an applicant submits an application that contains all required
information and pays the applicable deleted text begin licensing deleted text end new text begin application new text end fee, the office must review the
application.

(b) The office may deny an application if:

(1) the application is incomplete;

(2) the application contains a materially false statement about the applicant or omits
information required under subdivision 1;

(3) the applicant does not meet the qualifications under section 342.16;

(4) the applicant is prohibited from holding the license under section 342.18, subdivision
2;

(5) the application does not meet the minimum requirements under section 342.18,
subdivision 3;

(6) the applicant fails to pay the applicable application fee;

(7) the application was not submitted by the application deadline;

(8) the applicant submitted more than one application for a license type; or

(9) the office determines that the applicant would be prohibited from holding a license
for any other reason.

(c) If the office denies an application, the office must notify the applicant of the denial
and the basis for the denial.

(d) The office may request additional information from any applicant if the office
determines that the information is necessary to review or process the application. If the
applicant does not provide the additional requested information within 14 calendar days of
the office's request for information, the office may deny the application.

(e) An applicant whose application is not denied under this subdivision is a qualified
applicant.

Sec. 30.

Minnesota Statutes 2024, section 342.14, subdivision 6, is amended to read:

Subd. 6.

Completed application; final authorization; issuance of license.

(a) Within
18 months of receiving notice of preliminary license approval, an applicant must provide:

(1) the address and legal property description of the location where the business will
operate;

(2) the name of the local unit of government where the business will be located; and

(3) if applicable, an updated description of the location where the business will operate,
an updated security plan, and any other additional information required by the office.

(b) Upon receipt of the information required under paragraph (a) from an applicant that
has received preliminary license approval, the office must:

(1) forward a copy of the application to the local unit of government in which the business
operates or intends to operate with a form for certification as to whether a proposed cannabis
business complies with local zoning ordinances and, if applicable, whether the proposed
business complies with the state fire code and building code;

(2) schedule a site inspection; and

(3) require the applicant to pay the applicable license fee.

(c) The office may deny final authorization if:

(1) an applicant fails to submit any required information;

(2) the applicant submits a materially false statement about the applicant or fails to
provide any required information;

(3) the office confirms that the cannabis business for which the office granted a
new text begin preliminary new text end license deleted text begin preapproval deleted text end new text begin approval new text end does not meet local zoning and land use laws;

(4) the applicant fails to pay the applicable license fee; or

(5) the office determines that the applicant is disqualified from holding the license or
would operate in violation of the provisions of this chapter.

(d) Within 90 days of receiving the information required under paragraph (a) and the
results of any required background check, the office shall grant final authorization and issue
the appropriate license or send the applicant a notice of rejection setting forth specific
reasons that the office did not approve the application.

Sec. 31.

Minnesota Statutes 2024, section 342.151, subdivision 2, is amended to read:

Subd. 2.

Criminal history check.

A deleted text begin license holder deleted text end new text begin cannabis business new text end may employ or
contract with as many unlicensed individuals as may be necessary, provided that the deleted text begin license
holder deleted text end new text begin cannabis business new text end is at all times accountable for the good conduct of every individual
employed by or contracted with the deleted text begin license holder deleted text end new text begin cannabis business new text end . Before hiring an
individual as a cannabis worker, the deleted text begin license holder deleted text end new text begin cannabis business new text end must submit to the
Bureau of Criminal Apprehension the individual's full set of fingerprints and written consent
for the bureau to conduct a state and national criminal history check. The bureau may
exchange an individual's fingerprints with the Federal Bureau of Investigation. The Bureau
of Criminal Apprehension must determine whether the individual is qualified to be employed
as a cannabis worker and must notify the deleted text begin license holder deleted text end new text begin cannabis business new text end of the bureau's
determination. The deleted text begin license holder deleted text end new text begin cannabis business new text end must not employ an individual who is
disqualified from being employed as a cannabis worker.

Sec. 32.

Minnesota Statutes 2024, section 342.151, subdivision 3, is amended to read:

Subd. 3.

Disqualification.

(a) A deleted text begin license holder deleted text end new text begin cannabis business new text end must not employ an
individual as a cannabis worker if the individual has been convicted of any of the following
crimes that would constitute a felony:

(1) human trafficking;

(2) noncannabis controlled substance crimes in the first or second degree;

(3) labor trafficking;

(4) fraud;

(5) embezzlement;

(6) extortion;

(7) money laundering; or

(8) insider trading;

if committed in this state or any other jurisdiction for which a full pardon or similar relief
has not been granted.

(b) A deleted text begin license holder deleted text end new text begin cannabis business new text end must not employ an individual as a cannabis
worker if the individual made any false statement in an application for employment.

Sec. 33.

Minnesota Statutes 2024, section 342.22, subdivision 3, is amended to read:

Subd. 3.

Issuance of registration.

(a) A local unit of government shall issue a retail
registration to a cannabis microbusiness with a retail operations endorsement, cannabis
mezzobusiness with a retail operations endorsement, cannabis retailer, medical cannabis
combination business operating a retail location, or lower-potency hemp edible retailer that:

(1) has a valid license or new text begin preliminary new text end license deleted text begin preapproval deleted text end new text begin approval new text end issued by the office;

(2) has paid the registration fee or renewal fee pursuant to subdivision 2;

(3) is found to be in compliance with the requirements of this chapter at any preliminary
compliance check that the local unit of government performs; and

(4) if applicable, is current on all property taxes and assessments at the location where
the retail establishment is located.

(b) Before issuing a retail registration, the local unit of government may conduct a
preliminary compliance check to ensure that the cannabis business or hemp business is in
compliance with any applicable local ordinance established pursuant to section 342.13.

(c) A local unit of government shall renew the retail registration of a cannabis business
or hemp business when the office renews the license of the cannabis business or hemp
business.

(d) A retail registration issued under this section may not be transferred.

Sec. 34.

Minnesota Statutes 2024, section 342.28, subdivision 1, is amended to read:

Subdivision 1.

Authorized actions.

A cannabis microbusiness license, consistent with
the specific license endorsement or endorsements, entitles the license holder to perform any
or all of the following within the limits established by this section:

(1) grow cannabis plants from seed or immature plant to mature plant and harvest
cannabis flower from a mature plant;

(2) make cannabis concentrate;

(3) make hemp concentrate, including hemp concentrate with a delta-9
tetrahydrocannabinol concentration of more than 0.3 percent as measured by weight;

(4) manufacture artificially derived cannabinoids;

(5) manufacture adult-use cannabis products, lower-potency hemp edibles, and
hemp-derived consumer products for public consumption;

(6) purchase immature cannabis plants and seedlings deleted text begin and deleted text end new text begin , new text end cannabis flower new text begin , cannabis
products, lower-potency hemp edibles, and hemp-derived consumer products new text end from another
cannabis microbusiness, a cannabis mezzobusiness, new text begin a cannabis cultivator, new text end a cannabis
manufacturer, deleted text begin or deleted text end a cannabis wholesaler new text begin , or a lower-potency hemp edible manufacturer new text end ;

(7) purchase hemp plant parts and propagules from an industrial hemp grower licensed
under chapter 18K;

(8) purchase hemp concentrate from an industrial hemp processor licensed under chapter
18K;

(9) purchase cannabis concentrate, hemp concentrate, and artificially derived cannabinoids
from another cannabis microbusiness, a cannabis mezzobusiness, a cannabis manufacturer,
or a cannabis wholesaler for use in manufacturing adult-use cannabis products, lower-potency
hemp edibles, or hemp-derived consumer products;

(10) package and label adult-use cannabis flower, adult-use cannabis products,
lower-potency hemp edibles, and hemp-derived consumer products for sale to customers;

(11) sell immature cannabis plants and seedlings, adult-use cannabis flower, adult-use
cannabis products, lower-potency hemp edibles, hemp-derived consumer products, and
other products authorized by law to other cannabis businesses and to customers;

(12) operate an establishment that permits on-site consumption of edible cannabis
products and lower-potency hemp edibles; and

(13) perform other actions approved by the office.

Sec. 35.

Minnesota Statutes 2024, section 342.28, subdivision 8, is amended to read:

Subd. 8.

Production of deleted text begin customer deleted text end new text begin consumer new text end products endorsement.

A cannabis
microbusiness that manufactures edible cannabis products, lower-potency hemp products,
or hemp-derived consumer products must comply with the requirements in section 342.26,
subdivisions 2 and 4.

Sec. 36.

Minnesota Statutes 2024, section 342.29, subdivision 1, is amended to read:

Subdivision 1.

Authorized actions.

A cannabis mezzobusiness license, consistent with
the specific license endorsement or endorsements, entitles the license holder to perform any
or all of the following within the limits established by this section:

(1) grow cannabis plants from seed or immature plant to mature plant and harvest
cannabis flower from a mature plant for use as adult-use cannabis flower or for use in
adult-use cannabis products;

(2) grow cannabis plants from seed or immature plant to mature plant and harvest
cannabis flower from a mature plant for use as medical cannabis flower or for use in medical
cannabinoid products;

(3) make cannabis concentrate;

(4) make hemp concentrate, including hemp concentrate with a delta-9
tetrahydrocannabinol concentration of more than 0.3 percent as measured by weight;

(5) manufacture artificially derived cannabinoids;

(6) manufacture adult-use cannabis products, lower-potency hemp edibles, and
hemp-derived consumer products for public consumption;

(7) process medical cannabinoid products;

(8) purchase immature cannabis plants and seedlings deleted text begin and deleted text end new text begin , new text end cannabis flower new text begin , cannabis
products, lower-potency hemp edibles, and hemp-derived consumer products new text end from a cannabis
microbusiness, another cannabis mezzobusiness, new text begin a cannabis cultivator, new text end a cannabis
manufacturer, deleted text begin or deleted text end a cannabis wholesaler new text begin , or a lower-potency hemp edible manufacturer new text end ;

(9) purchase cannabis concentrate, hemp concentrate, and deleted text begin synthetically deleted text end new text begin artificially new text end derived
cannabinoids from a cannabis microbusiness, another cannabis mezzobusiness, a cannabis
manufacturer, or a cannabis wholesaler for use in manufacturing adult-use cannabis products,
lower-potency hemp edibles, or hemp-derived consumer products;

(10) purchase hemp plant parts and propagules from a licensed hemp grower licensed
under chapter 18K;

(11) purchase hemp concentrate from an industrial hemp processor licensed under chapter
18K;

(12) package and label adult-use cannabis flower, adult-use cannabis products,
lower-potency hemp edibles, and hemp-derived consumer products for sale to customers;

(13) sell immature cannabis plants and seedlings, adult-use cannabis flower, adult-use
cannabis products, lower-potency hemp edibles, hemp-derived consumer products, and
other products authorized by law to other cannabis businesses and to customers; and

(14) perform other actions approved by the office.

Sec. 37.

Minnesota Statutes 2024, section 342.29, subdivision 7, is amended to read:

Subd. 7.

Production of deleted text begin customer deleted text end new text begin consumer new text end products endorsement.

A cannabis
mezzobusiness that manufactures edible cannabis products, lower-potency hemp products,
or hemp-derived consumer products must comply with the requirements in section 342.26,
subdivisions 2 and 4.

Sec. 38.

Minnesota Statutes 2024, section 342.30, subdivision 1, is amended to read:

Subdivision 1.

Authorized actions.

A cannabis cultivator license entitles the license
holder to new text begin :
new text end

new text begin (1) new text end grow cannabis plants within the approved amount of space from seed or immature
plant to mature plant deleted text begin , deleted text end new text begin ;
new text end

new text begin (2) new text end harvest cannabis flower from a mature plant deleted text begin , deleted text end new text begin ;
new text end

new text begin (3) new text end package and label immature cannabis plants and seedlings and cannabis flower for
sale to other cannabis businesses deleted text begin , deleted text end new text begin ;
new text end

new text begin (4) sell immature cannabis plants and seedlings and cannabis flower to other cannabis
businesses;
new text end

new text begin (5) new text end transport cannabis flower to a cannabis manufacturer located on the same premises deleted text begin , deleted text end new text begin ; new text end
and

new text begin (6) new text end perform other actions approved by the office.

Sec. 39.

Minnesota Statutes 2024, section 342.33, subdivision 1, is amended to read:

Subdivision 1.

Authorized actions.

A cannabis wholesaler license entitles the license
holder to:

(1) purchase immature cannabis plants and seedlings, cannabis flower, cannabis products,
lower-potency hemp edibles, and hemp-derived consumer products from cannabis
microbusinesses, cannabis mezzobusinesses, cannabis cultivators, cannabis manufacturers,
and deleted text begin cannabis microbusinesses deleted text end new text begin lower-potency hemp edible manufacturers new text end ;

(2) purchase hemp plant parts and propagules from industrial hemp growers licensed
under chapter 18K;

(3) purchase hemp concentrate from an industrial hemp processor licensed under chapter
18K;

(4) sell immature cannabis plants and seedlings, cannabis flower, cannabis products,
lower-potency hemp edibles, and hemp-derived consumer products to cannabis
microbusinesses, cannabis mezzobusinesses, cannabis manufacturers, and cannabis retailers;

(5) sell lower-potency hemp edibles to lower-potency hemp edible retailers;

(6) import hemp-derived consumer products and lower-potency hemp edibles that contain
hemp concentrate or artificially derived cannabinoids that are derived from hemp plants or
hemp plant parts; and

(7) perform other actions approved by the office.

Sec. 40.

Minnesota Statutes 2024, section 342.44, subdivision 1, is amended to read:

Subdivision 1.

Application; contents.

(a) Except as otherwise provided in this
subdivision, the provisions of this chapter relating to license applications, license selection
criteria, general ownership disqualifications and requirements, and general operational
requirements do not apply to hemp businesses.

(b) The office deleted text begin , by rule, deleted text end shall establish forms and procedures for the processing of hemp
licenses issued under this chapter. At a minimum, any application to obtain or renew a hemp
license shall include the following information, if applicable:

(1) the name, address, and date of birth of the applicant;

(2) the address and legal property description of the business;

(3) proof of trade name registration;

(4) certification that the applicant will comply with the requirements of this chapter
relating to the ownership and operation of a hemp business;

(5) identification of one or more controlling persons or managerial employees as agents
who shall be responsible for dealing with the office on all matters; and

(6) a statement that the applicant agrees to respond to the office's supplemental requests
for information.

(c) An applicant for a lower-potency hemp edible manufacturer license must submit an
attestation signed by a bona fide labor organization stating that the applicant has entered
into a labor peace agreement.

(d) An application on behalf of a corporation or association shall be signed by at least
two officers or managing agents of that entity.

Sec. 41.

Minnesota Statutes 2024, section 342.46, subdivision 6, is amended to read:

Subd. 6.

Compliant products.

(a) A lower-potency hemp edible retailer shall ensure
that all lower-potency hemp edibles offered for sale comply with the limits on the amount
and types of cannabinoids that a lower-potency hemp edible can contain, including but not
limited to the requirement that lower-potency hemp edibles:

(1) consist of servings that contain no more than five milligrams of delta-9
tetrahydrocannabinol, no more than 25 milligrams of cannabidiol, no more than 25 milligrams
of cannabigerol, or any combination of those cannabinoids that does not exceed the identified
amounts;

(2) do not contain more than a combined total of 0.5 milligrams of all other cannabinoids
per serving; and

(3) do not contain an artificially derived cannabinoid other than delta-9
tetrahydrocannabinol.

(b) If a lower-potency hemp edible is packaged in a manner that includes more than a
single serving, the lower-potency hemp edible must indicate each serving by scoring,
wrapping, or other indicators that appear on the lower-potency hemp edible designating the
individual serving size. deleted text begin If it is not possible to indicate a single serving by scoring or use of
another indicator that appears on the product, the lower-potency hemp edible may not be
packaged in a manner that includes more than a single serving in each container, except
that a calibrated dropper, measuring spoon, or similar device for measuring a single serving
may be used for any edible cannabinoid products that are intended to be combined with
food or beverage products prior to consumption. If the lower-potency hemp edible is meant
to be consumed as a beverage, the beverage container may not contain more than two
servings per container. deleted text end new text begin If the lower-potency hemp edible is meant to be consumed as a
beverage, the beverage container must not contain more than two servings.
new text end

new text begin (c) Notwithstanding paragraph (b), any edible cannabinoid products that are intended
to be combined with food or beverage products before consumption must indicate a single
serving using one of the following methods:
new text end

new text begin (1) the product is packaged in individual servings;
new text end

new text begin (2) the product indicates a single serving by scoring or use of another indicator that
appears on the product; or
new text end

new text begin (3) the product is sold with a calibrated dropper, measuring spoon, or similar device for
measuring a single serving.
new text end

deleted text begin (c) deleted text end new text begin (d) new text end A single package containing multiple servings of a lower-potency hemp edible
must contain no more than 50 milligrams of delta-9 tetrahydrocannabinol, 250 milligrams
of cannabidiol, 250 milligrams of cannabigerol, or any combination of those cannabinoids
that does not exceed the identified amounts.

Sec. 42.

Minnesota Statutes 2024, section 342.52, is amended by adding a subdivision to
read:

new text begin Subd. 7a. new text end

new text begin Allowable delivery methods. new text end

new text begin A patient in the registry program may receive
medical cannabis flower and medical cannabinoid products. The office may approve
additional delivery methods to expand the types of products that qualify as medical
cannabinoid products.
new text end

Sec. 43.

Minnesota Statutes 2024, section 342.57, subdivision 2, is amended to read:

Subd. 2.

Criminal and civil protections.

(a) Subject to section 342.56, the following
are not violations of this chapter or chapter 152:

(1) use or possession of medical cannabis flower, medical cannabinoid products, or
medical cannabis paraphernalia by a patient enrolled in the registry program deleted text begin or by a visiting
patient deleted text end to whom medical cannabis flower or medical cannabinoid products are distributed
under section 342.51, subdivision 5;

(2) possession of medical cannabis flower, medical cannabinoid products, or medical
cannabis paraphernalia by a registered designated caregiver or a parent, legal guardian, or
spouse of a patient enrolled in the registry program; or

(3) possession of medical cannabis flower, medical cannabinoid products, or medical
cannabis paraphernalia by any person while carrying out duties required under sections
342.51 to 342.60.

(b) The Office of Cannabis Management, members of the Cannabis Advisory Council,
Office of Cannabis Management employees, agents or contractors of the Office of Cannabis
Management, and health care practitioners participating in the registry program are not
subject to any civil penalties or disciplinary action by the Board of Medical Practice, the
Board of Nursing, or any business, occupational, or professional licensing board or entity
solely for participating in the registry program either in a professional capacity or as a
patient. A pharmacist licensed under chapter 151 is not subject to any civil penalties or
disciplinary action by the Board of Pharmacy when acting in accordance with sections
342.51 to 342.60 either in a professional capacity or as a patient. Nothing in this section
prohibits a professional licensing board from taking action in response to a violation of law.

(c) Notwithstanding any law to the contrary, a Cannabis Advisory Council member, the
governor, or an employee of a state agency must not be held civilly or criminally liable for
any injury, loss of property, personal injury, or death caused by any act or omission while
acting within the scope of office or employment under sections 342.51 to 342.60.

(d) Federal, state, and local law enforcement authorities are prohibited from accessing
the registry except when acting pursuant to a valid search warrant. Notwithstanding section
13.09, a violation of this paragraph is a gross misdemeanor.

(e) Notwithstanding any law to the contrary, the office and employees of the office must
not release data or information about an individual contained in any report or document or
in the registry and must not release data or information obtained about a patient enrolled in
the registry program, except as provided in sections 342.51 to 342.60. Notwithstanding
section 13.09, a violation of this paragraph is a gross misdemeanor.

(f) No information contained in a report or document, contained in the registry, or
obtained from a patient under sections 342.51 to 342.60 may be admitted as evidence in a
criminal proceeding, unless:

(1) the information is independently obtained; or

(2) admission of the information is sought in a criminal proceeding involving a criminal
violation of sections 342.51 to 342.60.

(g) Possession of a registry verification or an application for enrollment in the registry
program:

(1) does not constitute probable cause or reasonable suspicion;

(2) must not be used to support a search of the person or property of the person with a
registry verification or application to enroll in the registry program; and

(3) must not subject the person or the property of the person to inspection by any
government agency.

Sec. 44.

Minnesota Statutes 2024, section 342.59, subdivision 2, is amended to read:

Subd. 2.

Allowable use; prohibited use.

Data specified in subdivision 1 may be used
to comply with chapter 13, to comply with a request from the legislative auditor or the state
auditor in the performance of official duties, and for purposes specified in sections deleted text begin 342.47 deleted text end
new text begin 342.51 new text end to 342.60. Data specified in subdivision 1 and maintained by the Office of Cannabis
Management or Division of Medical Cannabis must not be used for any purpose not specified
in sections deleted text begin 342.47 deleted text end new text begin 342.51 new text end to 342.60 and must not be combined or linked in any manner
with any other list, dataset, or database. Data specified in subdivision 1 must not be shared
with any federal agency, federal department, or federal entity unless specifically ordered
to do so by a state or federal court.

Sec. 45.

Minnesota Statutes 2024, section 342.61, subdivision 4, is amended to read:

Subd. 4.

Testing of samples; disclosures.

(a) On a schedule determined by the office,
every cannabis microbusiness, cannabis mezzobusiness, cannabis cultivator, cannabis
manufacturer, cannabis wholesaler with an endorsement to import products, lower-potency
hemp edible manufacturer, or medical cannabis combination business shall make each batch
of cannabis flower, cannabis products, artificially derived cannabinoids, lower-potency
hemp edibles, or hemp-derived consumer products grown, manufactured, or imported by
the cannabis business or hemp business available to a cannabis testing facility.

(b) A cannabis microbusiness, cannabis mezzobusiness, cannabis cultivator, cannabis
manufacturer, cannabis wholesaler with an endorsement to import products, lower-potency
hemp edible manufacturer, or medical cannabis combination business must disclose all
known information regarding pesticides, fertilizers, solvents, or other foreign materials,
including but not limited to catalysts used in creating artificially derived cannabinoids,
applied or added to the batch of cannabis flower, cannabis products, artificially derived
cannabinoids, lower-potency hemp edibles, or hemp-derived consumer products subject to
testing. Disclosure must be made to the cannabis testing facility and must include information
about all applications by any person, whether intentional or accidental.

(c) deleted text begin The deleted text end new text begin A new text end cannabis deleted text begin testing facility deleted text end new text begin business new text end shall select one or more representative
samples from each batch, test the samples for the presence of contaminants, and test the
samples for potency and homogeneity and to allow the cannabis flower, cannabis product,
artificially derived cannabinoid, lower-potency hemp edible, or hemp-derived consumer
product to be accurately labeled with its cannabinoid profile. Testing for contaminants must
include testing for residual solvents, foreign material, microbiological contaminants, heavy
metals, pesticide residue, mycotoxins, and any items identified pursuant to paragraph (b),
and may include testing for other contaminants. A cannabis testing facility must destroy or
return to the cannabis business or hemp business any part of the sample that remains after
testing.

Sec. 46.

Minnesota Statutes 2024, section 342.63, subdivision 2, is amended to read:

Subd. 2.

Content of label; cannabis.

All cannabis flower and hemp-derived consumer
products that consist of hemp plant parts sold to customers or patients must have affixed
on the packaging or container of the cannabis flower or hemp-derived consumer product a
label that contains at least the following information:

(1) the name and license number of the cannabis microbusiness, cannabis mezzobusiness,
cannabis cultivator, medical cannabis combination business, or industrial hemp grower
where the cannabis flower or hemp plant part was cultivated;

(2) the net weight deleted text begin or volume deleted text end of cannabis flower or hemp plant parts in the package or
container;

(3) the batch number;

(4) the cannabinoid profile;

(5) a universal symbol established by the office indicating that the package or container
contains cannabis flower, a cannabis product, a lower-potency hemp edible, or a
hemp-derived consumer product;

(6) verification that the cannabis flower or hemp plant part was tested according to
section 342.61 and that the cannabis flower or hemp plant part complies with the applicable
standards;

(7) information on the usage of the cannabis flower or hemp-derived consumer product;

(8) the following statement: "Keep this product out of reach of children."; and

(9) any other statements or information required by the office.

Sec. 47.

Minnesota Statutes 2024, section 342.63, subdivision 3, is amended to read:

Subd. 3.

Content of label; cannabinoid products.

(a) All cannabis products,
lower-potency hemp edibles, new text begin hemp concentrate, new text end hemp-derived consumer products other
than products subject to the requirements under subdivision 2, medical cannabinoid products,
and hemp-derived topical products sold to customers or patients must have affixed to the
packaging or container of the cannabis product a label that contains at least the following
information:

(1) the name and license number of the cannabis microbusiness, cannabis mezzobusiness,
cannabis cultivator, medical cannabis combination business, or industrial hemp grower that
cultivated the cannabis flower or hemp plant parts used in the cannabis product,
lower-potency hemp edible, hemp-derived consumer product, or medical cannabinoid
product;

(2) the name and license number of the cannabis microbusiness, cannabis mezzobusiness,
cannabis manufacturer, lower-potency hemp edible manufacturer, medical cannabis
combination business, or industrial hemp grower that manufactured the cannabis concentrate,
hemp concentrate, or artificially derived cannabinoid and, if different, the name and license
number of the cannabis microbusiness, cannabis mezzobusiness, cannabis manufacturer,
lower-potency hemp edible manufacturer, or medical cannabis combination business that
manufactured the product;

(3) the net weight deleted text begin or volume deleted text end of the cannabis product, lower-potency hemp edible, or
hemp-derived consumer product in the package or container;

(4) the type of cannabis product, lower-potency hemp edible, or hemp-derived consumer
product;

(5) the batch number;

(6) the serving size;

(7) the cannabinoid profile per serving and in total;

(8) a list of ingredients;

(9) a universal symbol established by the office indicating that the package or container
contains cannabis flower, a cannabis product, a lower-potency hemp edible, or a
hemp-derived consumer product;

(10) a warning symbol developed by the office in consultation with the commissioner
of health and the Minnesota Poison Control System that:

(i) is at least three-quarters of an inch tall and six-tenths of an inch wide;

(ii) is in a highly visible color;

(iii) includes a visual element that is commonly understood to mean a person should
stop;

(iv) indicates that the product is not for children; and

(v) includes the phone number of the Minnesota Poison Control System;

(11) verification that the cannabis product, lower-potency hemp edible, hemp-derived
consumer product, or medical cannabinoid product was tested according to section 342.61
and that the cannabis product, lower-potency hemp edible, hemp-derived consumer product,
or medical cannabinoid product complies with the applicable standards;

(12) information on the usage of the product;

(13) the following statement: "Keep this product out of reach of children."; and

(14) any other statements or information required by the office.

(b) The office may by rule establish alternative labeling requirements for lower-potency
hemp edibles that are imported into the state if those requirements provide consumers with
information that is substantially similar to the information described in paragraph (a).

Sec. 48.

Minnesota Statutes 2024, section 342.63, subdivision 6, is amended to read:

Subd. 6.

Additional information.

(a) A cannabis microbusiness, cannabis mezzobusiness,
cannabis retailer, or medical cannabis combination business must provide customers and
patients with the following information:

(1) factual information about impairment effects and the expected timing of impairment
effects, side effects, adverse effects, and health risks of cannabis flower, cannabis products,
lower-potency hemp edibles, and hemp-derived consumer products;

(2) a statement that customers and patients must not operate a motor vehicle or heavy
machinery while under the influence of cannabis flower, cannabis products, lower-potency
hemp edibles, and hemp-derived consumer products;

(3) resources customers and patients may consult to answer questions about cannabis
flower, cannabis products, lower-potency hemp edibles, and hemp-derived consumer
products, and any side effects and adverse effects;

(4) contact information for the poison control center and a safety hotline or website for
customers to report and obtain advice about side effects and adverse effects of cannabis
flower, cannabis products, lower-potency hemp edibles, and hemp-derived consumer
products;

(5) substance use disorder treatment options; and

(6) any other information specified by the office.

(b) A cannabis microbusiness, cannabis mezzobusiness, cannabis retailer, or medical
cannabis combination business may include the information described in paragraph (a) new text begin by:
new text end

new text begin (1) including the information new text end on the label affixed to the packaging or container of cannabis
flower, cannabis products, lower-potency hemp edibles, and hemp-derived consumer products
deleted text begin by: deleted text end new text begin ;
new text end

deleted text begin (1) deleted text end new text begin (2) new text end posting the information in the premises of the cannabis microbusiness, cannabis
mezzobusiness, cannabis retailer, or medical cannabis combination business; or

deleted text begin (2) deleted text end new text begin (3) new text end providing the information on a separate document or pamphlet provided to
customers or patients when the customer purchases cannabis flower, a cannabis product, a
lower-potency hemp edible, or a hemp-derived consumer product.

Sec. 49. new text begin REPEALER.
new text end

new text begin Minnesota Statutes 2024, sections 152.22, subdivision 2; 342.01, subdivision 71; and
342.151, subdivision 1, new text end new text begin are repealed.
new text end

APPENDIX

Repealed Minnesota Statutes: 25-00281

152.22 DEFINITIONS.

Subd. 2.

Commissioner.

"Commissioner" means the commissioner of health.

342.01 DEFINITIONS.

Subd. 71.

Visiting patient.

"Visiting patient" means an individual who is not a Minnesota resident and who possesses a valid registration verification card or its equivalent that is issued under the laws or regulations of another state, district, commonwealth, or territory of the United States verifying that the individual is enrolled in or authorized to participate in that jurisdiction's medical cannabis or medical marijuana program.

342.151 EMPLOYEES OF LICENSE HOLDERS.

Subdivision 1.

Definitions.

For purposes of this section, a "license holder" includes a cannabis microbusiness, cannabis mezzobusiness, cannabis cultivator, cannabis manufacturer, cannabis retailer, cannabis wholesaler, cannabis transporter, cannabis testing facility, cannabis event organizer, cannabis delivery service, lower-potency hemp edible manufacturer, lower-potency hemp edible retailer, or medical cannabis combination business.